Clinical Trial Update: ADAGiO: Adoptive Cellular Therapy for the TreAtment of Recurrent OliGodendrogliOma (OG) Adult Patients [Phase 1]

View source ↗

Summary

A Phase 1 trial of the ADAGiO adoptive cellular therapy for adult patients with recurrent or progressive oligodendroglioma; the study is currently active but no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oligodendroglioma

Drugs mentioned

• ADAGiO adoptive cellular therapy

Snippet

Sponsor: University of Florida | Conditions: Recurrent Oligodendroglioma, Progressive Oligodendroglioma | Phase 1 | Status: ACTIVE_NOT_RECRUITING